Filing Details
- Accession Number:
- 0001179110-13-016519
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-13 20:19:27
- Reporting Period:
- 2013-11-11
- Filing Date:
- 2013-11-13
- Accepted Time:
- 2013-11-13 20:19:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1578845 | Actavis Plc | ACT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1499481 | O Sigurdur Olafsson | 1 Grand Canal Square, Docklands Dublin 2 L2 00000 | Pres.-Actavis Pharma | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2013-11-11 | 25,000 | $159.87 | 71,947 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighed average price. These shares were sold in multiple transactions at prices ranging from $159.70 to $160.21, inclusive. The reporting person undertakes to provide Actavis plc, any security holder of Actavis plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
Billionaire Hedge Funds
